# Safety Study of GNbAC1 Monoclonal Antibody in Healthy Male Volunteers

> **NCT02452996** · PHASE1 · COMPLETED · sponsor: **GeNeuro Innovation SAS** · enrollment: 21 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** GNbAC1

## Key facts

- **NCT ID:** NCT02452996
- **Lead sponsor:** GeNeuro Innovation SAS
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 21 (ESTIMATED)
- **Last updated:** 2020-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02452996

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02452996, "Safety Study of GNbAC1 Monoclonal Antibody in Healthy Male Volunteers". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02452996. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*